- Home
- ONL vs ORMP Comparison
ONL vs ORMP Comparison
Compare ONL & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONL | ORMP |
|---|---|---|
| Founded | 2021 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4M | 197.6M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ONL | ORMP |
|---|---|---|
| Price | $2.10 | $4.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 318.0K | 136.7K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | 3.70% | ★ 6.04% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 0.19 | ★ 2.76 |
| Revenue | ★ $147,647,000.00 | $2,000,000.00 |
| Revenue This Year | $1.67 | N/A |
| Revenue Next Year | $0.11 | N/A |
| P/E Ratio | $11.32 | ★ $1.50 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $1.89 | $2.09 |
| 52 Week High | $3.05 | $5.47 |
Technical Indicators
Market Signals| Indicator | ONL | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 36.49 | 35.45 |
| Support Level | $2.02 | $3.91 |
| Resistance Level | $2.59 | $4.22 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 35.11 | 32.12 |
Price Performance
Historical ComparisonAbout ONL Orion Office REIT Inc.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.